Jianfan Biotech: A Notice on the Conditions for the Expected Downward Adjustment of the Conversion Price

NightAirdropper · 2026-04-10T12:15:55+00:00

Jianfan Biotech announced that if its stock closes below 85% of the conversion price for more than fifteen trading days within thirty consecutive trading days, it will have the right to propose a revision of the conversion price. This condition has recently been triggered, and the company must follow regulations to carry out review and information disclosure.

NightAirdropper

2026-04-10 12:15:55

Abstract generation in progress

Securities Daily Online News — On April 7, Jianfan Biotech announced that according to the company’s “Jianfan Biotech Group Co., Ltd. Growth Enterprise Market Issuance of Convertible Bonds to Unspecified Objects Prospectus” (referred to as the “Prospectus”): During the life of the convertible bonds, if the company’s stock closes at a price below 85% of the current conversion price for at least fifteen trading days within any thirty consecutive trading days, the company’s board of directors has the right to propose a downward adjustment to the conversion price and submit it for shareholder approval. From March 24, 2026, to April 7, 2026, the company’s stock has had ten trading days below the current conversion price at 85%. If the “Jianfan Convertible Bond” conversion price adjustment conditions are triggered, the company will promptly follow the review procedures and information disclosure obligations as stipulated in the “Prospectus.” Investors are advised to pay attention to investment risks.

(Edited by Ren Shibi)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.